Medicure Statistics
Total Valuation
Medicure has a market cap or net worth of CAD 8.66 million. The enterprise value is 2.35 million.
Market Cap | 8.66M |
Enterprise Value | 2.35M |
Important Dates
The last earnings date was Wednesday, April 9, 2025.
Earnings Date | Apr 9, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Medicure has 10.44 million shares outstanding. The number of shares has increased by 1.42% in one year.
Current Share Class | n/a |
Shares Outstanding | 10.44M |
Shares Change (YoY) | +1.42% |
Shares Change (QoQ) | -1.78% |
Owned by Insiders (%) | 25.26% |
Owned by Institutions (%) | 0.62% |
Float | 5.24M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 0.40 |
PB Ratio | 0.42 |
P/TBV Ratio | 1.08 |
P/FCF Ratio | n/a |
P/OCF Ratio | 6.29 |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -2.26 |
EV / Sales | 0.11 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.89, with a Debt / Equity ratio of 0.04.
Current Ratio | 1.89 |
Quick Ratio | 1.49 |
Debt / Equity | 0.04 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -66.76 |
Financial Efficiency
Return on equity (ROE) is -5.11% and return on invested capital (ROIC) is -8.13%.
Return on Equity (ROE) | -5.11% |
Return on Assets (ROA) | -5.93% |
Return on Invested Capital (ROIC) | -8.13% |
Return on Capital Employed (ROCE) | -12.86% |
Revenue Per Employee | 576,500 |
Profits Per Employee | -27,342 |
Employee Count | 38 |
Asset Turnover | 0.76 |
Inventory Turnover | 2.85 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -22.43% in the last 52 weeks. The beta is 0.69, so Medicure's price volatility has been lower than the market average.
Beta (5Y) | 0.69 |
52-Week Price Change | -22.43% |
50-Day Moving Average | 0.80 |
200-Day Moving Average | 0.91 |
Relative Strength Index (RSI) | 51.05 |
Average Volume (20 Days) | 3,170 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Medicure had revenue of CAD 21.91 million and -1.04 million in losses. Loss per share was -0.10.
Revenue | 21.91M |
Gross Profit | 13.09M |
Operating Income | -2.74M |
Pretax Income | -783,000 |
Net Income | -1.04M |
EBITDA | -1.01M |
EBIT | -2.74M |
Loss Per Share | -0.10 |
Balance Sheet
The company has 7.19 million in cash and 874,000 in debt, giving a net cash position of 6.32 million or 0.61 per share.
Cash & Cash Equivalents | 7.19M |
Total Debt | 874,000 |
Net Cash | 6.32M |
Net Cash Per Share | 0.61 |
Equity (Book Value) | 20.78M |
Book Value Per Share | 1.99 |
Working Capital | 7.50M |
Cash Flow
Operating Cash Flow | 1.38M |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross margin is 59.75%, with operating and profit margins of -12.49% and -4.74%.
Gross Margin | 59.75% |
Operating Margin | -12.49% |
Pretax Margin | -3.57% |
Profit Margin | -4.74% |
EBITDA Margin | -4.63% |
EBIT Margin | -12.49% |
FCF Margin | n/a |
Dividends & Yields
Medicure does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -1.42% |
Shareholder Yield | -1.42% |
Earnings Yield | -11.99% |
FCF Yield | n/a |
Stock Splits
The last stock split was on November 2, 2012. It was a reverse split with a ratio of 0.0666666.
Last Split Date | Nov 2, 2012 |
Split Type | Reverse |
Split Ratio | 0.0666666 |
Scores
Medicure has an Altman Z-Score of -1.66. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -1.66 |
Piotroski F-Score | n/a |